Aspergillosis primary prevention: Difference between revisions

Jump to navigation Jump to search
YazanDaaboul (talk | contribs)
No edit summary
WikiBot (talk | contribs)
m Changes made per Mahshid's request
 
Line 15: Line 15:
{{reflist|2}}
{{reflist|2}}
[[Category:Fungal diseases]]
[[Category:Fungal diseases]]
[[Category:Infectious disease]]

Latest revision as of 17:01, 18 September 2017

Aspergillosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Aspergillosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Aspergillosis primary prevention On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Aspergillosis primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Aspergillosis primary prevention

CDC on Aspergillosis primary prevention

Aspergillosis primary prevention in the news

Blogs on Aspergillosis primary prevention

Aspergillosis

Risk calculators and risk factors for Aspergillosis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]; Yazan Daaboul, M.D.; Serge Korjian M.D.

Overview

There is no vaccine against Aspergillus. Effective preventive measures include avoiding exposure to Aspergillus by personal protective equipment in dusty environments around construction sites, avoiding activities that require exposure to soil (such as yard work or gardening), and properly cleaning wounds. Prophylactic antifungal drugs is not recommended for the general population. Pharmacologic prophylaxis may be helpful in individual cases among immunocompromised patients.

Primary Prevention

  • There is no vaccine against Aspergillus.
  • Effective preventive measures include
  • Avoiding exposure to Aspergillus by personal protective equipment in dusty environments around construction sites
  • Avoiding activities that require exposure to soil (such as yard work or gardening)
  • Properly cleaning wounds
  • Using air quality improvement measures, such as HEPA filters
  • Prophylactic antifungal drugs is not recommended for the general population. Pharmacologic prophylaxis may be helpful in individual cases among immunocompromised patients.

References